XML 56 R44.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-Based Compensation, Stock Option and Restricted Shares (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2018
Mar. 31, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
2009 Employee Option Plan            
Stock-Based Compensation            
Number of additional stock options that will be granted (in shares)       0    
Options ratable vesting period       5 years    
Options exercisable period       10 years    
2017 Employee Option Plan            
Stock-Based Compensation            
Common Stock reserved for issuance 30,000,000     30,000,000    
Shares available for the granting of additional stock options 16,947,280     16,947,280    
Options ratable vesting period       5 years    
Options exercisable period       10 years    
2004 Directors Option Plan            
Stock-Based Compensation            
Options exercisable period       10 years    
Stock Options            
Stock option activity            
Options outstanding at the beginning of the period (in shares) 32,587,575 33,222,364   33,222,364    
Options granted (in shares) 6,111,100          
Options exercised (in shares) (740,046) (602,549)        
Options forfeited (in shares) (116,740) (32,240)        
Options outstanding at the end of the period (in shares) 37,841,889 32,587,575   37,841,889   33,222,364
Vested and non-vested options expected to vest at the end of the period (in shares) 35,378,287     35,378,287    
Exercisable at the end of the period (in shares) 18,269,909     18,269,909    
Weighted Average Exercise Price            
Weighted average exercise price, options outstanding at the beginning of the period (in dollars per share) $ 52.58 $ 52.27   $ 52.27    
Weighted average exercise price, options outstanding at the end of the period (in dollars per share) 58.50 $ 52.58   58.50   $ 52.27
Weighted average exercise price, vested and non-vested options expected to vest (in dollars per share) 57.63     57.63    
Weighted average exercise price, exercisable (in dollars per share) $ 45.14     $ 45.14    
Weighted Average Remaining Contractual Term            
Weighted average remaining contractual term of options outstanding   6 years 10 months 2 days   7 years 1 month 24 days   7 years 18 days
Weighted average remaining contractual term of options vested options and non-vested expected to vest       7 years 22 days    
Weighted average remaining contractual term of options exercisable       5 years 7 months 24 days    
Aggregate Intrinsic Value            
Aggregate intrinsic value of options outstanding $ 1,089.4 $ 1,093.2   $ 1,089.4   $ 1,180.3
Aggregate intrinsic value of options, vested and non-vested options expected to vest 1,048.7     1,048.7    
Aggregate intrinsic value of options exercisable $ 767.5     $ 767.5    
Status of the Company's non-vested options and changes during the year            
Non-vested options at the beginning of the period (in shares) 19,500,800 19,600,440   19,600,440    
Options granted (in shares) 6,111,100          
Non-vested options, options vested (in shares) (5,923,180) (67,400)        
Non-vested options, options forfeited (in shares) (116,740) (32,240)        
Non-vested options at the end of the period (in shares) 19,571,980 19,500,800   19,571,980   19,600,440
Weighted Average Fair Value at Grant Date            
Weighted average fair value at the grant date, options outstanding at the beginning of the period (in dollars per share) $ 8.29 $ 8.29   $ 8.29    
Weighted average fair value at grant date, options granted (in dollars per share) 12.82          
Weighted average fair value at grant date, options vested (in dollars per share) 8.35 8.13        
Weighted average fair value at grant date, options forfeited (in dollars per share) 8.18 8.56        
Weighted average fair value at the grant date, options outstanding at the end of the period (in dollars per share) $ 9.69 $ 8.29   $ 9.69   $ 8.29
Fair Value at Grant Date            
Total intrinsic value of stock options exercised (in dollars) $ 35.1   $ 79.6 $ 69.4 $ 114.1  
Total fair value of stock options vested (in dollars) 49.5   $ 44.8 50.0 $ 45.5  
Total compensation cost related to non-vested options not yet recognized (in dollars) $ 165.9     $ 165.9    
Weighted average expected amortization period       3 years 9 months    
Restricted Shares | 2012 Directors Restricted Stock Plan            
Stock-Based Compensation            
Shares available for the granting of additional stock options 109,695     109,695    
Restricted share activity            
Restricted shares outstanding at the beginning of the period (in shares) 12,905 12,905   12,905    
Restricted shares granted (in shares) 14,469          
Shares vested and issued (in shares) (13,046)          
Restricted shares outstanding at the end of the period (in shares) 14,328 12,905   14,328   12,905
Fair Value at Grant Date            
Fair value at the grant date, restricted shares outstanding at the beginning of the period (in dollars per share) $ 73.25 $ 73.25   $ 73.25    
Fair value of restricted shares vested and issued (in dollar per share) 73.35          
Fair value of restricted shares granted (in dollars per share) 87.93          
Fair value at the grant date, restricted shares outstanding at the end of the period (in dollars per share) $ 87.98 $ 73.25   $ 87.98   $ 73.25
Weighted Average Remaining Amortization Term (in years)   1 month 17 days   10 months 17 days   4 months 13 days
Total compensation cost related to non-vested restricted shares not yet recognized (in dollars) $ 1.1     $ 1.1    
Weighted average expected amortization period       10 months 17 days